Hypofractionation for radiotherapy of prostate cancer using a low alfa/beta ratio – possible reasons for concerns? An example of five dimensional radiotherapy
Authors:
- Bo LennernäsBLBo Lennernäs
- Sten NilssonSNSten Nilsson
- Seymour LevittSLSeymour Levitt
- 23 May 2011
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 50 (sup1) , 111-115
Abstract
It is very attractive, due to the assumed low alfa/beta ratio of prostate cancer (PC), to construct new treatment schedules for prostate cancer using only a few large fractions of radiation (hypofractionation). This will widen the therapeutic window since the ratio for PC might be lower than that of the organs at risk (OAR). PC is an extremely variable disease and often contains both highly and poorly differentiated cells. It is reasonable to assume that different cells have different patterns of radiosensitivity, i.e. alfa/beta ratios and proliferation. In this study we will simulate the effect on the outcome of the treatment with different fractionations and different ratios. Material and methods. In this simulation we use an extension of the Linear Quadratic (LQ)/Biological Effective Dose (BED) formula called the dose volume inhomogenity corrected BED (DVIC-BED). In the formula the tumour volume is divided in 50 subvolumes (step of 2%) and it is possible to calculate the relative effect of the treatment with different ratios (1.5, 4 and 6.5) in different subvolumes. Results. The simulations demonstrate that only a small portion (5–10%) of cells with a higher ratio will dramatically change the effect of the treatment. Increasing the total dose can compensate this, but this will on the other hand increase the dose to the OAR and also the risk for severe side effects. Conclusion. These simulations highlight possible reasons for concerns about the use of hypofractionation for pathologically heterogeneous tumours, such as prostate cancer, and also demonstrate the need for testing new treatment schedules using both high and low ratios.Keywords
This publication has 9 references indexed in Scilit:
- When tumor repopulation starts? The onset time of prostate cancer during radiation therapyActa Oncologica, 2010
- The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995Radiotherapy and Oncology, 2010
- External Beam Radiotherapy for Prostate CancerJournal of Endourology, 2010
- The prostate cancer pseudo-epidemicActa Oncologica, 2010
- Biological Factors Influencing Optimum Fractionation in Radiation TherapyActa Oncologica, 2001
- Calculated Effects of Displacement Errors in External Beam Radiotherapy of Prostatic AdenocarcinomaActa Oncologica, 1999
- Prostate Specific Antigen and Gleason Grade: An Immunohistochemical Study of Prostate CancerJournal of Urology, 1994
- Radiation sensitization by estramustine studies on cultured human prostatic cancer cellsThe Prostate, 1992
- The linear-quadratic formula and progress in fractionated radiotherapyBritish Journal of Radiology, 1989